Skip to main content

Table 2 Antibiotic resistance of invasive P. aeruginosa

From: Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection

Countrya

No. of isolates

No. of isolates (%) non-susceptible to

MDR

Aminoglycoside

Carbapenem

Cephalosporin

Fluoroquinolone

β-lactamase inhibitor

Monobactam

Amikacin

Gentamicin

Meropenem

Cefepime

Levofloxacin

Piperacillin-tazobactam

Aztreonam

USAb

116

0 (0)

10 (8.6)

23 (19.8)

10 (8.6)

48 (41.4)

24 (21.0)

56 (48.3)

28 (24.1)

USAc

51

0 (0)

7 (14.0)

9 (17.6)

5 (10.0)

21 (41.2)

13 (25.5)

27 (53.0)

14 (27.4)

Denmark

35

2 (5.7)

2 (5.7)

6 (17.1)

5 (14.3)

20 (57.1)

5 (14.3)

27 (77.1)

8 (22.8)

Sweden

25

2 (8.0)

2 (8.0)

4 (16.0)

2 (8.0)

9 (36.0)

3 (12.0)

6 (24.0)

5 (20.0)

South Africa

50

8 (16.0)

15 (30.0)

18 (36.0)

17 (34.0)

25 (50.0)

15 (30.0)

42 (84.0)

20 (40.0)

Mali

24

1 (4.2)

1 (4.2)

0 (0)

0 (0)

1 (4.2)

0 (0)

8 (33.3)

0 (0)

DR Congo

3

0 (0)

2 (66.7)

1 (33.3)

1 (33.3)

2 (66.7)

2 (66.7)

2 (66.7)

2 (66.7)

Japan

14

0 (0)

0 (0)

4 (28.6)

0 (0)

4 (28.6)

0 (0)

7 (50.0)

2 (14.3)

Singapore

25

2 (8.0)

7 (28.0)

9 (36.0)

9 (36.0)

12 (48.0)

10 (40.0)

16 (64.0)

11 (44.0)

Pakistan

27

6 (22.2)

6 (22.2)

8 (29.6)

8 (29.6)

14 (51.8)

9 (33.3)

15 (55.5)

9 (33.3)

Overall

370

21 (5.7)

52 (14.0)

82 (22.2)

57 (15.4)

156 (42.2)

81 (22.0)

206 (55.7)

99 (26.7)

  1. aIsolates collected from Greece were excluded
  2. bIsolates were obtained from University of Maryland Medical Center
  3. cIsolates were obtained from Duke University Medical Center